Author:
Kerwin Edward M.,Gotfried Mark H.,Lawrence David,Lassen Cheryl,Kramer Benjamin
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study;Feldman;BMC Pulm Med,2010
2. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium;Donohue;Am J Respir Crit Care Med,2010
3. Once-daily indacaterol vs twice-daily salmeterol for COPD: a placebo-controlled comparison;Kornmann;Eur Respir J,2011
4. Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD;Dahl;Thorax,2010
5. Long-term safety and efficacy of indacaterol, a novel long-acting β2-agonist, in subjects with COPD: a randomized, placebo-controlled study;Chapman;Chest,2011
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献